BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31924245)

  • 1. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
    Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
    Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable sources of Bk virus in renal allograft recipients.
    Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
    J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
    Kaur A; Wilhelm M; Wilk S; Hirsch HH
    Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
    Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
    BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
    Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
    J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients.
    Huang HX; Xiang Y; George R; Winterberg P; Serluco A; Liverman R; Yildirim I; Garro R
    Pediatr Transplant; 2024 Aug; 28(5):e14791. PubMed ID: 38808701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.
    Solis M; Velay A; Porcher R; Domingo-Calap P; Soulier E; Joly M; Meddeb M; Kack-Kack W; Moulin B; Bahram S; Stoll-Keller F; Barth H; Caillard S; Fafi-Kremer S
    J Am Soc Nephrol; 2018 Jan; 29(1):326-334. PubMed ID: 29042457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.
    Teutsch K; Schweitzer F; Knops E; Kaiser R; Pfister H; Verheyen J; Göbel H; Cingöz T; Di Cristanziano V
    Med Microbiol Immunol; 2015 Dec; 204(6):657-64. PubMed ID: 25749892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.